Streetbeat News

Regulatory

RYVYL

RYVYL has received a letter from Nasdaq stating that the company is not in compliance with the market value of listed securities standard, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:11 pm

ALVO

Alvotech SA has filed for a mixed shelf offering of up to $100 million, according to a SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:10 pm

DBX

Dropbox Inc. has entered into a lease amendment for its corporate headquarters, surrendering 165,244 square feet of office space and paying $79.0 million in termination payments. The termination payment of $28.1 million paid in Q4 2023 was not previously factored into the company's full-year free cash flow guidance range of $820 million to $840 million.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:09 pm

BMRN

The U.S. Food and Drug Administration (FDA) has approved BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) supplemental New Drug Application (sNDA) for VOXZOGO® (vosoritide) to increase linear growth in pediatric patients with achondroplasia. Previously, VOXZOGO was indicated for children who were 5 years of age and older. This expanded indication now includes children of all ages with open growth plates. The company has seen strong patient demand for the medicine worldwide and has secured increased fill-finish commitments in 2024 and beyond to meet this additional demand.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:09 pm

COMS

COMSovereign Holding Corp. (NASDAQ:COMS) has received a notice from the Nasdaq Listing Qualifications Staff indicating that the company's securities will be delisted from Nasdaq due to non-compliance with the filing requirement. The company has not yet filed its Form 10-K for the year ended December 31, 2022, and Forms 10-Q for the periods ended March 31, 2023, and June 30, 2023. COMSovereign plans to request a hearing before the Nasdaq Hearings Panel to present its plan to comply with Nasdaq's filing requirement and request an extension.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:08 pm

BTCUSD

DOGEUSD

ETHUSD

Bitcoin (BTC) led the crypto sector higher during Friday's trading session amid optimism about the approval of a spot Bitcoin ETF. BlackRock and Fidelity made changes to their Bitcoin ETF submissions, while Grayscale filed an S-3 application for similar approvals. Bitcoin, Ethereum (ETH), and Dogecoin (DOGE) are trading in patterns that suggest potential bullish movements. However, Ethereum and Dogecoin are currently trading in bear cycles.

Portfolio Pulse from Melanie Schaffer

October 20, 2023 | 8:08 pm

FSNB

Fusion Acquisition Corp. II has received a notice from the New York Stock Exchange (NYSE) regarding the immediate suspension of trading of its securities. The NYSE has also commenced delisting proceedings against the company.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:06 pm

SGLY

Singularity Future Technology has regained compliance with Nasdaq's Listing Rule 5620(A), as per a formal notification received from Nasdaq on October 19.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:05 pm

GOSS

Gossamer Bio Inc has received a notice of delisting or failure to satisfy a continued listing rule or standard from Nasdaq, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:05 pm

PM

Philip Morris International (PMI) has submitted applications to the U.S. FDA to commercialize its IQOS ILUMA heated tobacco products. The company is seeking an order to market these products as modified risk products that reduce exposure to harmful chemicals. IQOS ILUMA products are currently available in 27 international markets and have demonstrated higher rates of full switching by adults who smoke. PMI will have full rights to commercialize all IQOS products in the U.S. as of April 30, 2024, per an agreement with Altria Group.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:03 pm